FDMT 4D Molecular Therapeutics, Inc.
Fundamentals / CIK 0001650648 / USD4D Molecular Therapeutics, Inc. reported $96.06M in revenue and a net loss of $200.4M for the trailing twelve months ended September 30, 2026 (up 4505.6% year over year), with a -226.0% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open FDMT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$96.06M +4505.6% YoY
-
Operating Income TTM-$217.1M -226.0% margin
-
Net Income TTM-$200.4M -208.6% net margin
-
Diluted EPS TTM-$2.77 Split-adjusted
-
Free Cash Flow TTM-$109.6M -114.1% FCF margin
-
Cash & ST Investments Sep 30, 2026$307.0M Total debt: $38.41M
Annual revenue and net income
7 fiscal years (2019 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $85.21M | $37K | $20.72M | $3.13M | $18.04M | $13.61M | $6.99M |
| Research & Development | $195.7M | $141.3M | $97.10M | $80.25M | $61.36M | $53.04M | $38.72M |
| Total Operating Expenses | $244.8M | $187.9M | $133.6M | $113.2M | $89.37M | $70.28M | $57.75M |
| Operating Income | -$159.5M | -$187.8M | -$112.9M | -$110.0M | -$71.33M | -$56.66M | -$50.76M |
| EBITDA | -$154.9M | -$183.2M | -$108.7M | -$107.6M | -$69.81M | -$55.22M | -$49.76M |
| Interest Income | $19.48M | $27.05M | $12.21M | $2.57M | $137K | $152K | $1.50M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | -- |
| Net Income | -$140.1M | -$160.9M | -$100.8M | -$107.5M | -$71.32M | -$56.69M | -$49.31M |
| Basic EPS | -$2.42 | -$2.98 | -$2.58 | -$3.32 | -$2.57 | -$8.82 | -$9.59 |
| Diluted EPS | -$2.42 | -$2.98 | -$2.58 | -$3.32 | -$2.57 | -$8.82 | -$9.59 |
| Basic Shares Outstanding | 57.9M | 53.9M | 39.1M | 32.4M | 27.7M | 6.4M | 5.1M |
| Diluted Shares Outstanding | 57.9M | 53.9M | 39.1M | 32.4M | 27.7M | 6.4M | 5.1M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.14M | $3.78M | $3.05M | $85.09M | $90K | $15K | $14K | $1.0K |
| Research & Development | $69.78M | $68.28M | $64.98M | $57.61M | $49.44M | $47.95M | $40.70M | $43.09M |
| Total Operating Expenses | $85.36M | $80.81M | $76.67M | $70.38M | $61.27M | $59.47M | $53.63M | $56.12M |
| Operating Income | -$81.22M | -$77.03M | -$73.62M | $14.71M | -$61.19M | -$59.46M | -$53.62M | -$56.12M |
| EBITDA | -$80.00M | -$75.75M | -$72.35M | $15.93M | -$59.92M | -$58.29M | -$52.57M | -$55.02M |
| Interest Income | $3.94M | $4.25M | $4.86M | $4.70M | $4.33M | $4.86M | $5.58M | $6.47M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$78.06M | -$72.94M | -$68.76M | $19.40M | -$56.88M | -$54.66M | -$47.97M | -$49.67M |
| Basic EPS | -$1.08 | -$1.04 | -$1.01 | -- | -$1.01 | -$0.98 | -$0.86 | -- |
| Diluted EPS | -$1.08 | -$1.04 | -$1.01 | -- | -$1.01 | -$0.98 | -$0.86 | -- |
| Basic Shares Outstanding | 72.3M | 70.3M | 68.1M | -- | 56.1M | 55.9M | 55.7M | -- |
| Diluted Shares Outstanding | 72.3M | 70.3M | 68.1M | -- | 56.1M | 55.9M | 55.7M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $60.24M | $149.3M | $249.1M | $52.35M | $153.0M | $276.7M | $49.65M |
| Short-Term Investments | $342.4M | $275.5M | $39.12M | $161.2M | $94.78M | $0 | -- |
| Cash & Short-Term Investments | $514.0M | $424.9M | $288.2M | $213.6M | $247.8M | $276.7M | $49.65M |
| Accounts Receivable, Net | -- | -- | -- | $0 | $47K | $1.49M | $978K |
| Total Current Assets | $413.1M | $434.9M | $296.6M | $220.5M | $256.3M | $282.7M | $52.51M |
| Property, Plant & Equipment, Net | $14.87M | $19.53M | $20.13M | $22.26M | $14.39M | $5.07M | $5.05M |
| Long-Term Investments | $111.4M | $80.58M | $10.95M | $4.91M | $67.65M | $0 | -- |
| Other Non-Current Assets | $9.19M | $4.26M | $684K | $1.08M | $602K | $602K | $677K |
| Total Non-Current Assets | $153.6M | $125.5M | $43.30M | $41.34M | $97.21M | $5.67M | $5.73M |
| Total Assets | $566.7M | $560.4M | $339.9M | $261.8M | $353.5M | $288.3M | $58.23M |
| Accounts Payable | $11.16M | $4.39M | $3.52M | $3.32M | $4.76M | $1.79M | $1.74M |
| Deferred Revenue (Current) | $360K | $257K | $273K | $884K | $2.60M | $6.59M | $5.86M |
| Total Current Liabilities | $43.98M | $29.15M | $18.95M | $15.73M | $16.34M | $16.74M | $12.96M |
| Long-Term Debt | $0 | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | $745K | $1.06M | $972K | $1.08M | $2.49M | $13.23M | $13.60M |
| Other Non-Current Liabilities | $138K | $193K | $248K | $21K | $120K | $1.85M | $1.56M |
| Total Non-Current Liabilities | $17.06M | $20.63M | $13.11M | $14.78M | $18.04M | $15.20M | $15.27M |
| Total Liabilities | $61.05M | $49.78M | $32.06M | $30.51M | $34.38M | $31.94M | $28.22M |
| Total Debt (incl. Leases) | $21.41M | $24.61M | $14.67M | $16.12M | $16.45M | -- | -- |
| Common Stock | $6.0K | $5.0K | $4.0K | $3.0K | $3.0K | $3.0K | $1.0K |
| Retained Earnings | -$716.3M | -$576.2M | -$415.3M | -$314.5M | -$207.0M | -$135.7M | -$79.03M |
| Accumulated Other Comp. Income | $727K | $229K | $16K | -$1.20M | -$423K | $0 | -- |
| Total Stockholders' Equity | $505.7M | $510.6M | $307.8M | $231.3M | $319.1M | $256.4M | -$72.97M |
| Total Equity | $505.7M | $510.6M | $307.8M | $231.3M | $319.1M | $256.4M | -$72.97M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $39.10M | $70.37M | $72.49M | $60.24M | $48.55M | $77.16M | $133.5M | $149.3M |
| Short-Term Investments | $267.9M | $291.0M | $318.4M | $342.4M | $256.5M | $216.1M | $187.9M | $275.5M |
| Cash & Short-Term Investments | $307.0M | $361.3M | $390.9M | $514.0M | $305.1M | $293.2M | $321.4M | $424.9M |
| Total Current Assets | $322.3M | $383.0M | $405.4M | $413.1M | $312.4M | $303.3M | $332.6M | $434.9M |
| Property, Plant & Equipment, Net | $11.22M | $12.38M | $13.59M | $14.87M | $16.15M | $17.50M | $18.75M | $19.53M |
| Long-Term Investments | $68.04M | $69.30M | $66.74M | $111.4M | $67.17M | $123.8M | $137.0M | $80.58M |
| Other Non-Current Assets | $11.44M | $11.44M | $9.86M | $9.19M | $9.38M | $9.39M | $7.04M | $4.26M |
| Total Non-Current Assets | $106.5M | $109.7M | $107.5M | $153.6M | $111.6M | $170.3M | $183.2M | $125.5M |
| Total Assets | $428.7M | $492.6M | $512.9M | $566.7M | $424.0M | $473.6M | $515.7M | $560.4M |
| Accounts Payable | $7.88M | $12.52M | $14.69M | $11.16M | $6.86M | $8.70M | $4.15M | $4.39M |
| Deferred Revenue (Current) | $360K | $360K | $360K | $360K | $360K | $1.07M | $866K | $257K |
| Total Current Liabilities | $52.39M | $47.67M | $43.40M | $43.98M | $37.11M | $34.68M | $26.90M | $29.15M |
| Long-Term Debt | $19.68M | $19.59M | -- | $0 | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | $2.83M | $2.96M | $2.12M | $745K | $835K | $219K | $434K | $1.06M |
| Other Non-Current Liabilities | $2.08M | $101K | $121K | $138K | $144K | $161K | $177K | $193K |
| Total Non-Current Liabilities | $38.41M | $37.28M | $17.66M | $17.06M | $17.89M | $18.07M | $19.11M | $20.63M |
| Total Liabilities | $90.81M | $84.96M | $61.07M | $61.05M | $55.00M | $52.75M | $46.01M | $49.78M |
| Total Debt (incl. Leases) | $38.41M | $39.22M | $20.54M | $21.41M | $22.26M | $23.08M | $23.85M | $24.61M |
| Common Stock | $6.0K | $6.0K | $5.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K |
| Retained Earnings | -$936.1M | -$858.0M | -$785.1M | -$716.3M | -$735.7M | -$678.8M | -$624.2M | -$576.2M |
| Accumulated Other Comp. Income | -$1.00M | -$446K | -$180K | $727K | $671K | $337K | $332K | $229K |
| Total Stockholders' Equity | $337.9M | $407.7M | $451.8M | $505.7M | $369.0M | $420.9M | $469.7M | $510.6M |
| Total Equity | $337.9M | $407.7M | $451.8M | $505.7M | $369.0M | $420.9M | $469.7M | $510.6M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Net Income | -$140.1M | -$160.9M | -$100.8M | -$107.5M | -$71.32M | -$56.69M | -$49.31M |
| Depreciation & Amortization | $4.69M | $4.65M | $4.20M | $2.40M | $1.52M | $1.44M | $1.00M |
| Stock-Based Compensation | $22.02M | $26.12M | $19.66M | $17.12M | $13.80M | $4.98M | $3.54M |
| Change in Receivables | -- | -- | $0 | $47K | $1.44M | -$508K | $146K |
| Change in Payables | $6.77M | $871K | $896K | -$1.64M | $2.29M | $43K | $533K |
| Operating Cash Flow | -$109.1M | -$134.6M | -$75.79M | -$86.69M | -$69.13M | -$50.91M | -$36.71M |
| Capital Expenditure | -$536K | -$3.79M | -$2.77M | -$11.54M | -$9.11M | -$1.00M | -$3.20M |
| Free Cash Flow | -$109.6M | -$138.4M | -$78.56M | -$98.22M | -$78.24M | -$51.91M | -$39.91M |
| Purchases of Investments | -$442.8M | -$467.7M | -$54.80M | -$153.3M | -$168.6M | $0 | -- |
| Investing Cash Flow | -$92.97M | -$302.4M | $115.7M | -$17.05M | -$172.7M | -$1.00M | -$3.20M |
| Common Stock Issued | -- | -- | -- | $0 | $114.3M | $205.7M | -- |
| Financing Cash Flow | $113.0M | $337.2M | $156.8M | $3.08M | $118.1M | $279.0M | -$2.19M |
| Net Change in Cash | -$89.09M | -$99.77M | $196.8M | -$100.7M | -$123.7M | $227.1M | -$42.11M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$78.06M | -$72.94M | -$68.76M | $19.40M | -$56.88M | -$54.66M | -$47.97M | -$49.67M |
| Depreciation & Amortization | $1.22M | $1.28M | $1.27M | $1.22M | $1.26M | $1.17M | $1.05M | $1.10M |
| Stock-Based Compensation | $8.26M | $5.88M | $4.45M | $5.55M | $4.52M | $4.96M | $6.99M | $7.58M |
| Change in Payables | -$2.94M | -$4.06M | $3.53M | $4.30M | -$1.84M | $4.55M | -$235K | $1.46M |
| Operating Cash Flow | -$56.71M | -$70.00M | -$68.12M | $28.55M | -$46.50M | -$43.38M | -$47.76M | -$45.86M |
| Capital Expenditure | -- | -- | -- | $70K | $91K | -$66K | -$631K | -$949K |
| Free Cash Flow | -- | -- | -- | $28.62M | -$46.41M | -$43.44M | -$48.39M | -$46.81M |
| Purchases of Investments | -$84.83M | -$62.04M | -$33.52M | -$178.1M | -$15.24M | -$115.4M | -$134.1M | -$57.78M |
| Investing Cash Flow | $24.84M | $25.54M | $68.89M | -$128.8M | $17.78M | -$13.85M | $31.95M | $7.06M |
| Financing Cash Flow | $604K | $42.34M | $11.48M | $112.0M | $116K | $862K | $0 | $601K |
| Net Change in Cash | -$31.27M | -$2.12M | $12.25M | $11.69M | -$28.60M | -$56.37M | -$15.81M | -$38.20M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -187.2% | -507678.4% | -544.6% | -3516.5% | -395.5% | -416.3% | -726.7% |
| Net Profit Margin | -164.4% | -434778.4% | -486.6% | -3435.4% | -395.4% | -416.5% | -705.8% |
| Return on Equity (ROE) | -27.7% | -31.5% | -32.8% | -46.5% | -22.3% | -22.1% | -- |
| Return on Assets (ROA) | -24.7% | -28.7% | -29.7% | -41.1% | -20.2% | -19.7% | -84.7% |
| Current Ratio | 9.39x | 14.92x | 15.65x | 14.02x | 15.69x | 16.88x | 4.05x |
| Quick Ratio | 11.69x | 14.58x | 15.21x | 13.58x | 15.17x | 16.62x | 3.91x |
| Debt to Equity | 0.04x | 0.05x | 0.05x | 0.07x | 0.05x | -- | -- |
| Revenue Growth (YoY) | +230194.6% | -99.8% | +562.3% | -82.7% | +32.5% | +94.8% | -- |
| 5Y Revenue / Share Growth | -30.5% | -99.9% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -226.0% | -214.2% | -203.5% | -187.2% | -191982.5% | -667654.5% | -884026.1% | -507678.4% |
| Net Profit Margin | -208.6% | -194.7% | -182.3% | -164.4% | -174314.2% | -594375.8% | -767126.1% | -434778.4% |
| Return on Equity (ROE) | -59.3% | -44.0% | -35.6% | -27.7% | -56.7% | -46.6% | -37.6% | -31.5% |
| Return on Assets (ROA) | -46.7% | -36.4% | -31.4% | -24.7% | -49.3% | -41.4% | -34.2% | -28.7% |
| Current Ratio | 6.15x | 8.03x | 9.34x | 9.39x | 8.42x | 8.75x | 12.36x | 14.92x |
| Quick Ratio | 5.86x | 7.58x | 9.01x | 11.69x | 8.22x | 8.46x | 11.95x | 14.58x |
| Debt to Equity | 0.11x | 0.10x | 0.05x | 0.04x | 0.06x | 0.05x | 0.05x | 0.05x |
| Revenue Growth (YoY) | +4505.6% | +25106.7% | +21664.3% | +8508900.0% | +2900.0% | +200.0% | -50.0% | -- |